×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Weekends – 8th Anniversary Edition

  • June 10, 2018

Welcome to the 8th anniversary edition of Insider Weekends. Publishing these series of posts continuously for eight years would not have been possible with the support of our wonderful staff and the technology our programmers built to help us extract and organize the data for insider transactions, mergers, spinoffs and more recently stock buybacks. We added two new features for premium subscribers related to stock buyback announcements and merger deal alerts last week and built the double dipper screen a few weeks ago. We have reinvested most of our revenue from the premium subscription business back into the website and hope to build out the premium destination for event-driven investors on the web.

Getting back to our regular programming, insider buying decreased almost by half last week with insiders purchasing $59.2 million of stock compared to $119.66 million in the week prior. Selling also decreased with insiders selling $1.61 billion of stock last week compared to $1.76 million in the week prior.

Sell/Buy Ratio: The insider Sell/Buy ratio is calculated by dividing the total insider sales in a given week by total insider purchases that week. The adjusted ratio for last week went up to 27.22. In other words, insiders sold more than 27 times as much stock as they purchased. The Sell/Buy ratio this week compares unfavorably with the prior week, when the ratio stood at 14.69.

Note: As mentioned in the first post in this series, certain industries have their preferred metrics such as same store sales for retailers, funds from operations (FFO) for REITs and revenue per available room (RevPAR) for hotels that provide a better basis for comparison than simple valuation metrics. However metrics like Price/Earnings, Price/Sales and Enterprise Value/EBITDA included below should provide a good starting point for analyzing the majority of stocks.

Notable Insider Buys:

1. Dova Pharmaceuticals, Inc. (DOVA): $28.81

Shares of this pharmaceutical company were acquired by 2 insiders:

Only plus or premium subscribers can access this post. Subscribe today.